Abcam plc (LON:ABC – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,226 ($15.40) and traded as high as GBX 1,259 ($15.82). Abcam shares last traded at GBX 1,226 ($15.40), with a volume of 6,372,291 shares trading hands.
Abcam Price Performance
The company has a debt-to-equity ratio of 31.60, a quick ratio of 0.89 and a current ratio of 1.27. The business has a 50 day simple moving average of GBX 1,226 and a 200-day simple moving average of GBX 1,226. The firm has a market cap of £2.81 billion and a price-to-earnings ratio of 20,433.33.
Abcam Company Profile
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Featured Stories
- Five stocks we like better than Abcam
- Investing in the High PE Growth Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.
